Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporationverified

ADPT

Price:

$5.26

Market Cap:

$775.70M

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory develo...[Read more]

Industry

Biotechnology

IPO Date

2019-06-27

Stock Exchange

NASDAQ

Ticker

ADPT

The Current Ratio as of November 2024 (TTM) for Adaptive Biotechnologies Corporation (ADPT) is 3.99

According to Adaptive Biotechnologies Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 3.99. This represents a change of -10.47% compared to the average of 4.46 of the last 4 quarters.

Adaptive Biotechnologies Corporation (ADPT) Historical Current Ratio (quarterly & annually)

How has ADPT Current Ratio performed in the past?

The mean historical Current Ratio of Adaptive Biotechnologies Corporation over the last ten years is 6.54. The current 3.99 Current Ratio has changed 6.00% with respect to the historical average. Over the past ten years (40 quarters), ADPT's Current Ratio was at its highest in in the September 2020 quarter at 8.70. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

6.54

Median

6.91

Minimum

3.54

Maximum

9.77

Adaptive Biotechnologies Corporation (ADPT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Adaptive Biotechnologies Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 44.69%

Maximum Annual Current Ratio = 9.77

Minimum Annual Increase = -48.79%

Minimum Annual Current Ratio = 3.54

Quarterly (TTM)
Annual
YearCurrent RatioChange
20234.66-8.98%
20225.1244.69%
20213.54-48.79%
20206.91-11.68%
20197.82-1.29%
20187.93-18.89%

Adaptive Biotechnologies Corporation (ADPT) Average Current Ratio

How has ADPT Current Ratio performed in the past?

The current Current Ratio of Adaptive Biotechnologies Corporation (ADPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.44

5-year avg

5.61

10-year avg

6.54

Adaptive Biotechnologies Corporation (ADPT) Current Ratio vs. Peers

How is ADPT’s Current Ratio compared to its peers?

Adaptive Biotechnologies Corporation’s Current Ratio is less than Verve Therapeutics, Inc. (14.64), less than Beam Therapeutics Inc. (5.81), less than Caribou Biosciences, Inc. (8.75), less than Sana Biotechnology, Inc. (5.20), less than VectivBio Holding AG (9.14), less than Kinnate Biopharma Inc. (13.19), less than Royalty Pharma plc (9.35), less than Ikena Oncology, Inc. (18.22), less than CohBar, Inc. (15.69), less than Hepion Pharmaceuticals, Inc. (5.62), less than Rain Therapeutics Inc. (5.58), less than Krystal Biotech, Inc. (7.97), less than AVROBIO, Inc. (26.17), less than Enveric Biosciences, Inc. (7.37), less than Elevation Oncology, Inc. (41.10), less than Zura Bio Limited (12.57), less than Reneo Pharmaceuticals, Inc. (57.86), less than Legend Biotech Corporation (4.84), less than Vir Biotechnology, Inc. (8.94), less than Apellis Pharmaceuticals, Inc. (5.08),

Build a custom stock screener for Adaptive Biotechnologies Corporation (ADPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adaptive Biotechnologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adaptive Biotechnologies Corporation (ADPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adaptive Biotechnologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Adaptive Biotechnologies Corporation's Current Ratio?

How is the Current Ratio calculated for Adaptive Biotechnologies Corporation (ADPT)?

What is the highest Current Ratio for Adaptive Biotechnologies Corporation (ADPT)?

What is the 3-year average Current Ratio for Adaptive Biotechnologies Corporation (ADPT)?

What is the 5-year average Current Ratio for Adaptive Biotechnologies Corporation (ADPT)?

How does the current Current Ratio for Adaptive Biotechnologies Corporation (ADPT) compare to its historical average?